Evidence map›Paper›PMID 20953964›Full record

ReviewJournal of anesthesia2010

Colloid solutions: a clinical update.

Tomi T Niemi, Ryo Miyashita, Michiaki Yamakage

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of anesthesia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03070353 (Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury), which is not on this map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03070353 phase2 / phase3completednot on this mapstarted 2015, after this paper: background citation

Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury

TypeinterventionalSponsorRamathibodi HospitalRan2015 to 2016Enrolled10ConditionsCirrhosis, Liver, AKIArmsDextran 40
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Review
  13. Adverse reactions to 6% hydroxyethyl starch in the operating room.Journal of clinical and diagnostic research : JCDR · 2013
    Article
  14. Article
  15. Article
  16. Reactive polymer enables efficient in vivo bioorthogonal chemistry.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tomi T NiemiDepartment of Anaesthesiology and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland.
Ryo Miyashita
Michiaki Yamakage

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Albumin, dextran, gelatin, and hydroxyethyl starch (HES) solutions are colloids that efficiently expand the circulating blood volume. The administration of colloids restores the intravascular volume with minimal risk of tissue edema in comparison with crystalloid solutions alone. However, colloids are always given for surgical and critically ill patients. The type of the colloid, volumes applied, aggressiveness of fluid resuscitation, and the volume status at the initial phase of administration determine their clinical responses. The outcome after fluid resuscitation with various colloids in critically ill patients seems to be comparable according to systematic reviews. A randomized, adequately powered clinical trial comparing modern nonprotein colloid to albumin is still lacking. Rapidly degradable HES solutions have good hemodynamic effects, and the risk of adverse renal and coagulation effects, as well as allergic reactions, is minimal. The current investigation has also shown the beneficial effect of HES solution (especially HES 130/0.4) on inflammatory response, postoperative nausea and vomiting, and postoperative outcome. The indication of colloids with an assessment of the degree of hypovolemia and safety profiles should thus be taken into consideration before colloid administration.

Indexed as

AlbuminsBlood CoagulationColloidsDextransGelatinHumansHydroxyethyl Starch DerivativesHypovolemiaInfusions, IntravenousKidney Function TestsMolecular WeightPlasma SubstitutesSolutionsSolventsAlbuminsColloidsDextransGelatinHydroxyethyl Starch DerivativesPlasma SubstitutesSolutionsSolvents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.